0

Journal Articles

in Drug Therapy
 81-100 of 342 Articles
Users' Guides to the Medical Literature |  September 26, 2012
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis
Edward J. Mills, PhD, MSc; John P. A. Ioannidis, MD, DSc; Kristian Thorlund, PhD, MSc; et al.
JAMA. 2012;308(12):1246-1253. doi:10.1001/2012.jama.11228.
INCLUDES: , Supplemental Content
Viewpoint |  September 19, 2012
FDA Approval of Obesity Drugs:  A Difference in Risk-Benefit Perceptions
Elaine H. Morrato, DrPH, MPH; David B. Allison, PhD
JAMA. 2012;308(11):1097-1098. doi:10.1001/jama.2012.10007.
Capitol Health Call |  September 12, 2012
Drug Gray Market
Mike Mitka
JAMA. 2012;308(10):964. doi:10.1001/2012.jama.11530.
Research Letters |  September 12, 2012 FREE
Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.
Medical News and Perspectives |  September 05, 2012
European Drug Agency Works to Improve Transparency, but Skepticism Remains
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.
Viewpoint |  September 05, 2012
The Safety Risks of Innovation:  The FDA's Expedited Drug Development Pathway
Thomas J. Moore, AB; Curt D. Furberg, MD, PhD
JAMA. 2012;308(9):869-870. doi:10.1001/jama.2012.9658.
Viewpoint |  September 05, 2012
Clinical Trial Data as a Public Good
Marc A. Rodwin, JD, PhD; John D. Abramson, MD, MS
JAMA. 2012;308(9):871-872. doi:10.1001/jama.2012.9661.
Medical News and Perspectives |  August 22, 2012
Methadone Overdose Deaths Rise With Increased Prescribing for Pain
Bridget M. Kuehn
JAMA. 2012;308(8):749-750. doi:10.1001/jama.2012.9289.
Capitol Health Call |  August 08, 2012
FDA Role in Drug Shortages
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.8914.
Capitol Health Call |  August 08, 2012
Incentives for New Antibiotics
Mike Mitka
JAMA. 2012;308(6):558. doi:10.1001/jama.2012.9558.
Medical News and Perspectives |  August 08, 2012
Oncology Drugs Enter the US Market Faster Than in Europe but Cost More
Mike Mitka
JAMA. 2012;308(6):555. doi:10.1001/jama.2012.9535.
Editorial |  July 25, 2012
Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection
James H. Stein, MD; Priscilla Y. Hsue, MD
JAMA. 2012;308(4):405-406. doi:10.1001/jama.2012.8488.
Viewpoint |  July 25, 2012 FREE
Toward an AIDS-Free Generation
Anthony S. Fauci, MD; Gregory K. Folkers, MS, MPH
JAMA. 2012;308(4):343-344. doi:10.1001/jama.2012.8142.
Editorial |  June 27, 2012
Toward a Safer Cure for Low-Risk Hodgkin Lymphoma in Children
Kimberly F. Whelan, MD, MSPH; Frederick D. Goldman, MD
JAMA. 2012;307(24):2639-2641. doi:10.1001/jama.2012.6975.
Health Agencies Update |  June 27, 2012
Fingolimod Precautions
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7064.
Health Agencies Update |  June 27, 2012
Mining Cast-off Drugs
Bridget M. Kuehn
JAMA. 2012;307(24):2578. doi:10.1001/jama.2012.7066.
Viewpoint |  June 20, 2012
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions:  Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
JAMA. 2012;307(23):2491-2492. doi:10.1001/jama.2012.5545.
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
Viewpoint |  June 13, 2012
The Cost of Drug Coupons
David Grande, MD, MPA
JAMA. 2012;307(22):2375-2376. doi:10.1001/jama.2012.5603.
Capitol Health Call |  May 09, 2012
Speeding Drug Approvals
Mike Mitka
JAMA. 2012;307(18):1904. doi:10.1001/jama.2012.4001.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems